ABBVIE INC. v. APOTEX INC. - 3:26-cv-11154

ABBVIE INC. v. APOTEX INC. (Case No. 3:26-cv-11154), filed on Aug 28, 2026 in the District Court, D. New Jersey involving patent infringement. This case involves patent infringement claims between the parties. Explore details about the litigants, key filings, and major docket updates.

Case Details

Case Number
3:26-cv-11154
Filing Date
Aug 28, 2026
Cause of Action
Patent Infringement
Status
-
Court
District Court, D. New Jersey
Nature of Suit
Patent - Abbreviated New Drug Application(ANDA)

Parties Involved

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
ABBVIE INC. -
APOTEX INC. -

Patents Involved

This case involves 2 patents, each of which is central to the dispute. These patents may be subject to claims of infringement, challenges to their validity, or other issues concerning their scope and enforcement.

Application NumberPatent Number
-US12622897B2
-US12661341B2

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Aug 28, 2026NOTICE of Appearance by MARK M. MAKHAIL on behalf of ABBVIE INC., ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED (MAKHAIL, MARK) (Entered: 08/28/2026)PACER Document
Aug 28, 2026Corporate Disclosure Statement by ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED identifying ABBVIE INC. as Corporate Parent.. (LINARES, JOSE) (Entered: 08/28/2026)PACER Document
Aug 28, 2026Corporate Disclosure Statement by ABBVIE INC.. (LINARES, JOSE) (Entered: 08/28/2026)PACER Document
Aug 28, 2026COMPLAINT against APOTEX INC. ( Filing and Admin fee $ 405 receipt number ANJDC-17872763), Related Case Selected, filed by ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED, ABBVIE INC.. (Attachments: # 1 Exhibit A - U.S. Patent No. 12,622,897, # 2 Exhibit B - U.S. Patent No. 12,661,341, # 3 Civil Cover Sheet)(LINARES, JOSE) (Entered: 08/28/2026)PACER Document
Aug 31, 2026SUMMONS ISSUED as to APOTEX INC. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (kht) (Entered: 08/31/2026)PACER Document
Aug 31, 2026AO120 Patent/Trademark Form filed. (kht) (Entered: 08/31/2026)PACER Document
Aug 28, 2026Judge Jennifer Choe-Groves (CIT) and Magistrate Judge J. Brendan Day added. (kht)PACER Document
Sep 1, 2026WAIVER OF SERVICE Returned Executed by ABBVIE INC., ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED. APOTEX INC. waiver sent on 8/31/2026, answer due 10/30/2026. (MAKHAIL, MARK) (Entered: 09/01/2026)PACER Document
Aug 28, 2026COMPLAINT against APOTEX INC. ( Filing and Admin fee $ 405 receipt number ANJDC-17872763), Related Case Selected, filed by ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED, ABBVIE INC.. (Attachments: # 1 Exhibit A - U.S. Patent No. 12,622,897, # 2 Exhibit B - U.S. Patent No. 12,661,341, # 3 Civil Cover Sheet)(LINARES, JOSE) (Entered: 08/28/2026)Attachment
Aug 28, 2026COMPLAINT against APOTEX INC. ( Filing and Admin fee $ 405 receipt number ANJDC-17872763), Related Case Selected, filed by ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED, ABBVIE INC.. (Attachments: # 1 Exhibit A - U.S. Patent No. 12,622,897, # 2 Exhibit B - U.S. Patent No. 12,661,341, # 3 Civil Cover Sheet)(LINARES, JOSE) (Entered: 08/28/2026)Attachment
Aug 28, 2026COMPLAINT against APOTEX INC. ( Filing and Admin fee $ 405 receipt number ANJDC-17872763), Related Case Selected, filed by ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED, ABBVIE INC.. (Attachments: # 1 Exhibit A - U.S. Patent No. 12,622,897, # 2 Exhibit B - U.S. Patent No. 12,661,341, # 3 Civil Cover Sheet)(LINARES, JOSE) (Entered: 08/28/2026)Attachment